MARKET

XENT

XENT

Intersect ENT
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.56
-0.18
-1.01%
After Hours: 17.56 0 0.00% 16:30 09/18 EDT
OPEN
17.87
PREV CLOSE
17.74
HIGH
18.46
LOW
17.17
VOLUME
434.19K
TURNOVER
--
52 WEEK HIGH
31.46
52 WEEK LOW
5.97
MARKET CAP
574.25M
P/E (TTM)
-9.1956
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average XENT stock price target is 18.93 with a high estimate of 30.00 and a low estimate of 10.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About XENT
Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology is designed to allow ENT physicians to manage patient care. The Company's commercial products are the PROPEL and PROPEL mini drug-releasing implants for patients undergoing sinus surgery to treat chronic sinusitis. The Company is building a portfolio of products based on its drug releasing bio-absorbable implant technology that are designed to provide localized drug delivery to treat patients across the continuum of care in chronic sinusitis. The Company markets PROPEL, which is indicated for use following ethmoid sinus surgery, and PROPEL Mini, which is indicated for use following ethmoid and/or frontal sinus surgery.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Intersect ENT Inc stock information, including NASDAQ:XENT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XENT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XENT stock methods without spending real money on the virtual paper trading platform.